Case Report
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation
Figure 2
(a) CXR before dabrafenib and trametinib initiation. (b) 1 week after treatment. Arrow shows pleural effusion.
| (a) |
| (b) |